Sue - Interview 47
Age at interview: 68
Age at diagnosis: 66
Brief Outline:
Sue was diagnosed with lung cancer in 2008. She had 4 cycles of chemotherapy, which was effective, but had bad side effects. When the tumour grew again in 2009 she started a biological therapy, erlotinib (Tarceva) with good results, and is still having it.
Background:
Sue is married and she has two grown-up children. She is a retired secretary. Ethnic background/nationality' White British.
More about me...
In September 2008 Sue noticed that her breathing sounded noisy, “like an instrument starting up”. She did not have any other symptoms. Her GP thought she might have asthma, and another GP in the practice gave her an inhaler. After a while Sue developed a lump in her neck, a swollen gland, and another GP prescribed antibiotics, and suggested a chest X-ray. Sue was shocked to learn that she had lung cancer.
Sue had a biopsy (of the lump in her neck), which showed that she had non-small cell lung cancer. She could not have surgery because of the location of the cancer (it was close to her windpipe) and she could not have radiotherapy because she had already had radiotherapy for breast cancer, so the treatment she was offered was chemotherapy.
Sue had four three week cycles of gemcitabine and cisplatin. During each cycle Sue had two sessions of chemotherapy as an out-patient, which was fine, and one session as an in-patient, which she found tiring and unpleasant. After each of the three week cycles of chemotherapy, Sue had a rest from chemotherapy for one week. This treatment was completed by the end of 2008.
The treatment cured the original symptoms, but Sue experienced quite bad side effects from chemotherapy. She felt cold and shivery, sick and weak, had terrible heart palpitations, felt breathless at times and she lost her hair. At the end of this treatment Sue was pleased to hear that the tumour had reduced in size by at least 50%.
After this treatment finished Sue had regular check-ups and chest X-rays. In September 2009 she had the disappointing news that the tumour had started to grow again. She was told that she could either have more chemotherapy, which might not be as effective as it had been the first time she had it, or she could try one of the new biological therapies, erlotinib (Tarceva). Sue decided to try the new treatment, which she still takes daily as a tablet. She didn’t want to have more chemotherapy because of the side effects and she hoped the new treatment would work.
The tablets of erlotinib again reduced the size of the tumour considerably, and now Sue continues with this treatment. She has had some side effects, mainly a skin rash, which cleared up with a steroid cream and antibiotics. On one occasion the rash was so bad that she had to take steroids by mouth. At times Sue also has dry skin and sore itchy eyes, which she treats with a moisturising cream and a form of artificial tears. She also feels very tired at times.
Sue has been taking erlotinib for nearly a year and a half, and she feels quite well. She goes back to the clinic every four weeks to have a check-up and to collect her next prescription. She has a chest X-ray every month and a CT scan about every three months. Sue is very well supported by her husband, family and friends.